Sleep and Glycemic Control in Type 2 Diabetes Adolescents

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 20
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
90 (estimated)
Sponsor
Children's Hospital of Philadelphia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving sleep goals can increase sleep duration in 15 adolescent patients diagnosed with T2DM with insuffici…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Aim 1 for child: 1. Subjects age 12-20 2. Diagnosed with T2DM by standard laboratory criteria without pancreatic autoimmunity 3. Low probability of obstructive sleep apnea (OSA) assessed via validated sleep survey 4. Subjects will be included if they are taking T2DM treatments …
Contacts

Talia Hitt, MD/MPH

215-590-3174

hittt@chop.edu

CONTACT

Beth Schwartzman

215-590-3174

schwartzmann@chop.edu

CONTACT